Citation Impact
Citing Papers
MUltiple Sclerosis and Extract of Cannabis: results of the MUSEC trial
2012
The global prevalence of dementia: A systematic review and metaanalysis
2013 Standout
Whole plant cannabis extracts in the treatment of spasticity in multiple sclerosis: a systematic review
2009
Charged-Higgs phenomenology in the aligned two-Higgs-doublet model
2010
The automated computation of tree-level and next-to-leading order differential cross sections, and their matching to parton shower simulations
2014 Standout
A Multicenter Dose-escalation Study of the Analgesic and Adverse Effects of an Oral Cannabis Extract (Cannador) for Postoperative Pain Management
2006
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
2005
Long-term Cognitive Impairment and Functional Disability Among Survivors of Severe Sepsis
2010 Standout
A cell-free platform for the prenylation of natural products and application to cannabinoid production
2019 StandoutNobel
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Cannabinoid CB1and CB2Receptors and Fatty Acid Amide Hydrolase Are Specific Markers of Plaque Cell Subtypes in Human Multiple Sclerosis
2007
Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation
2015 Standout
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
2004
2013 Alzheimer's disease facts and figures
2013 Standout
Cannabinoid-receptor 1 null mice are susceptible to neurofilament damage and caspase 3 activation
2005
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
2009
The safety of cannabinoids for the treatment of multiple sclerosis
2005
Adverse Health Effects of Marijuana Use
2014 Standout
Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods
2009
Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
2006
Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation
2005
Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial
2007
Emerging properties of cannabinoid medicines in management of multiple sclerosis
2005
What is self-rated health and why does it predict mortality? Towards a unified conceptual model
2009 Standout
The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids
2005
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
2007
Natural products: An evolving role in future drug discovery
2011 Standout
A Randomized, Double-Blinded, Crossover Pilot Study Assessing the Effect of Nabilone on Spasticity in Persons With Spinal Cord Injury
2010
Schizophrenia
2009 Standout
Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice
2006
Effects on Cell Viability
2005
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Recent Developments in Institutional Elder Care in China
2006
Pharmacological modulation of the endocannabinoid system in a viral model of multiple sclerosis
2005
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Cannabinoid-based drugs as anti-inflammatory therapeutics
2005
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
2007
A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and cannabidiol
2005
The endocannabinoid system and its therapeutic exploitation
2004
Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro
2006
Primary open-angle glaucoma
2004 Standout
Self-rated health status transition and long-term care need, of the oldest Chinese
2010
Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection
2004
Cancer-associated cachexia
2018 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Cannabinoid Control of Motor Function at the Basal Ganglia
2005
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Cannabinoids and Multiple Sclerosis
2007
A Three-Country Randomized Controlled Trial of a Psychosocial Intervention for Caregivers Combined With Pharmacological Treatment for Patients With Alzheimer Disease: Effects on Caregiver Depression
2008
The medicinal use of cannabis in the UK: results of a nationwide survey
2004
Cannabis, the mind and society: the hash realities
2007
Sleep in Spousal Alzheimer Caregivers: A Longitudinal Study with a Focus on the Effects of Major Patient Transitions on Sleep
2012
Cannabinoids and neuroprotection in CNS inflammatory disease
2005
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
Patient and Caregiver Characteristics and Nursing Home Placement in Patients With Dementia
2002
Control of Spasticity in a Multiple Sclerosis Model is mediated by CB1, not CB2, Cannabinoid Receptors
2007
Strength and vulnerability integration: A model of emotional well-being across adulthood.
2010 Standout
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
2007
Phytochemistry of Cannabis sativa L.
2017 Standout
Development of a New Patient-Reported Outcome Measure for Breast Surgery: The BREAST-Q
2009 Standout
Cannabinoids in medicine: A review of their therapeutic potential
2006
The effect of cannabis on urge incontinence in patients with multiple sclerosis: a multicentre, randomised placebo-controlled trial (CAMS-LUTS)
2006
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
2007 Standout
Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial
2012
Oral nabilone capsules in the treatment of chemotherapy-induced nausea and vomiting and pain
2007
Cannabinoids for the Treatment of Pain: An Update on Recent Clinical Trials
2005
Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations
2007
A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
2010
Can pharmacological treatment of behavioural disturbances in elderly patients with dementia lower the burden of their family caregiver?
2009
Cannabinoids for treatment of chronic non‐cancer pain; a systematic review of randomized trials
2011
Cannabis, Pain, and Sleep: Lessons from Therapeutic Clinical Trials of Sativex®, a Cannabis‐Based Medicine
2007
Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: a systematic review and analysis
2013 Standout
Human Cannabinoid Pharmacokinetics
2007 Standout
Nutzen einer Add-On-Therapie mit dem synthetischen Cannabinomimetikum Nabilone bei Patienten mit chronischen Schmerzzuständen – eine randomisierte kontrollierte Studie
2006
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial
2004
The Art of Sharing the Diagnosis and Management of Alzheimer’s Disease With Patients and Caregivers
2010
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Human Studies of Cannabinoids and Medicinal Cannabis
2005
Distinct Risk Factor Profiles for Human Papillomavirus Type 16–Positive and Human Papillomavirus Type 16–Negative Head and Neck Cancers
2008 Standout
Dementia care: mental health effects, intervention strategies, and clinical implications
2006
The problem with “problem behaviors”: a systematic review of the association between individual patient behavioral and psychological symptoms and caregiver depression and burden within the dementia patient–caregiver dyad
2012
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review
2015
Asymmetric dark matter
2009
The effect of a disease management intervention on quality and outcomes of dementia care: a randomized, controlled trial.
2006
Non pharmacological interventions for spasticity in multiple sclerosis
2013
The Origins of Health and Disease
2011
Human skin permeation of Δ8-tetrahydrocannabinol, cannabidiol and cannabinol
2004
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
2004
Therapeutic potential of cannabinoid receptor agonists as analgesic agents
2005
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
2005
Ghost-free braneworld bigravity
2004
Clinical Practice Recommendations
2011
Caregiver Burden
2014 Standout
Comparison of Orally Administered Cannabis Extract and Delta-9-Tetrahydrocannabinol in Treating Patients With Cancer-Related Anorexia-Cachexia Syndrome: A Multicenter, Phase III, Randomized, Double-Blind, Placebo-Controlled Clinical Trial From the Cannabis-In-Cachexia-Study-Group
2006
Are cannabinoids more effective than placebo in decreasing MS-related bladder dysfunction?
2012
Asymptotical AdS space from nonlinear gravitational models with stabilized extra dimensions
2002
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS
2012
Multiple Sclerosis
2018 Standout
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
2010 Standout
Targeting the CB2receptor for immune modulation
2006
A network theory of mental disorders
2017 Standout
2012 Alzheimer's disease facts and figures Alzheimer's Association ∗
2012 Standout
Symptomatic treatment of multiple sclerosis using cannabinoids: recent advances
2007
W and Z bosons in association with two jets using the POWHEG method
2013
Low energy effective theory for a two branes system: Covariant curvature formulation
2003
Between China and South Asia: A Middle Asian corridor of crop dispersal and agricultural innovation in the Bronze Age
2016 Standout
Nonstandard Higgs Boson Decays
2008
Cannabinoids in health and disease
2007
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Theory and phenomenology of two-Higgs-doublet models
2012 Standout
Meta-analysis of the efficacy and safety of Sativex (nabiximols), on spasticity in people with multiple sclerosis
2010
SARAH 3.2: Dirac gauginos, UFO output, and more
2013
Higgs-mediated FCNCs: natural flavour conservation vs. minimal flavour violation
2010
The Science of Marijuana
2007
FeynRules 2.0 — A complete toolbox for tree-level phenomenology
2014 Standout
The Medicinal Use of Cannabis and Cannabinoids—An International Cross-Sectional Survey on Administration Forms
2013
Early identification and treatment of Alzheimer's disease: Social and fiscal outcomes
2009
Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
2004
Family caregivers of people with dementia
2009 Standout
Long Distance Caregiving: An Evaluative Review of the Literature
2010
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Cannabinoids for Medical Use
2015 Standout
Development and evaluation of a multiplexed mass spectrometry based assay for measuring candidate peptide biomarkers in Alzheimer's Disease Neuroimaging Initiative (ADNI) CSF
2015 StandoutNobel
Network Analysis: An Integrative Approach to the Structure of Psychopathology
2013 Standout
Depression in informal caregivers of persons with dementia
2014
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
2015
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
2005
Plant, Synthetic, and Endogenous Cannabinoids in Medicine
2005
Small violations of unitarity, the phase inB s 0 − B ¯ s 0 t → c Z
2009
Next-to-minimal supersymmetric model close to theR h → a a m a < 2 m b
2007
Asymmetric dark matter
2014
Pharmacological and therapeutic targets for Δ9 tetrahydrocannabinol and cannabidiol
2004
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients
2004
Physiology of Microglia
2011 Standout
Multiple sclerosis following treatment with a cannabinoid receptor-1 antagonist
2004
Modified gravity and cosmology
2012 Standout
Efficacy of two cannabis‐based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial
2003
Works of Patrick J. Fox being referenced
Lessons Learned from the Medicare Alzheimer Disease Demonstration
2000
Population aging and the need for long term care: A comparison of the United States and the People's Republic of China
2000
2010
Patient and caregiver characteristics associated with depression in caregivers of patients with dementia
2003
Visible Cascade Higgs Decays to Four Photons at Hadron Colliders
2007
Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88)
2005
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial
2003 Standout
Taking a razor to dark matter parameter space at the LHC
2012
Wave function of the radion in the dS and AdS brane worlds
2001
Dirac Gaugino Masses and Supersoft Supersymmetry Breaking
2002
Next-to-leading order predictions for dark matter production at hadron colliders
2013
Deciphering top flavor violation at the CERN LHC withB
2008
Naturalness and Higgs decays in the MSSM with a singlet
2006